Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 September 2020 | Story Andre Damons | Photo Supplied
Dr Satyajit Tripathy
Dr Satyajit Tripathy, a postdoctoral fellow from the Department of Pharmacology and Physiology, won the medal for the best oral performance at a UNESCO/UNITWIN network web seminar attended by more than 300 people from various institutions around the world.

A postdoctoral fellow in Pharmacology at the University of the Free State (UFS) was awarded a medal for the best oral e-poster presentation (Postdoctoral Fellow category) at a UNESCO/UNITWIN Network web seminar.

The two-day webinar with the theme Current concepts of Environmental Pollution by Electromagnetic field and Coronavirus was held in early August and was attended by more than 300 delegates from approximately 30 institutions from different countries.

Dr Satyajit Tripathy from the Department of Pharmacology won the medal for his outstanding research presentation on Employment of old options to control novel Coronavirus: Pros and Cons (authors: Barsha Dassarma, Satyajit Tripathy, MG Matsabisa). His presentations looked at immunotherapeutic techniques, such as the convalescent plasma (CP) therapy and possible diverse modes of action of the antimalarial drug hydroxychloroquine (HCQ) against COVID-19 infection.

The award will serve as motivation

He was excited to hear that he had won the award, says Dr Tripathy.

“I never thought I would win, but I tried my best. On the topic of possible modes of action of HCQ against the viral infection, we have published in the ‘International Journal of Antimicrobial Agents’ (S Tripathy, B Dassarma, H Chabalala, S Roy, and MG Matsabisa / International Journal of Antimicrobial Agents 56 (2020) 106028). All the authors are grateful to Prof Glen Taylor, Research Director at the UFS, and the UFS Department of Pharmacology, for giving us the opportunity,” says Dr Tripathy. 
According to him, receiving this award is a validation and boost to his confidence. “I am thankful to Prof Motlalepula Matsabisa (supervisor) and Dr Barsha Dassarma (my wife), who are also contributing actively to this project. Moreover, the award is a symbol of respect for my work and the acceptance of a greater responsibility to keep the UFS flag flying high.”
Dr Tripathy goes further to say that it will motivate him to work on HCQ or nano-HCQ delivery research on Coronaviruses. In his doctoral study, it has been found that chitosan-based nanochloroquine delivery increases antimalarial efficacy against rodent parasites. Against the Coronavirus, this type of approach might work to reduce the dose and increase the efficacy of HCQ, explains Dr Tripathy. 

Immediate saviour from the pandemic

In his presentation, Dr Tripathy argues that while the world is finding expedited approvals for the development of vaccines that are time-dependent, preventative, and possibly not a cure, physicians are considering the convalescent plasma (CP) therapy as an immediate saviour, and the antimalarial drug hydroxychloroquine (HCQ) as therapeutic options against COVID-19 infection, after assessing results from larger prospective, randomised, dose-determining controlled clinical trials. 
He concludes that, “Overall, in this situation of unavailability of specific medication, the CP therapy and HCQ treatment might act as an immediate saviour for society from the pandemic.”

News Archive

SmartDrive devices give UFS wheelchair users more independence
2017-12-01

 Description: Cuads Tags: SmartDrive Power Assist, accessibility, Martie Miranda, CUADS, wheelchair users 

From the left, are: David Mashape; Martie Miranda, Head of the
Center for Universal Access and Disability Support at the UFS;
and Lawrence Qamba, celebrating the recent acquisition
of two SmartDrive Power Assist devices.
Photo: Johan Roux

Students who make use of wheelchairs at the University of the Free State (UFS) will now be able to move around campus more independently than before. This is thanks to two SmartDrive Power Assist devices acquired by the university.

Accessibility is very important to the institution and with these devices clipping onto a manual wheelchair to make it motorised, students will not have to ask for help that often. It will assist them in overcoming obstacles they face every day.

Different surfaces pose different challenges 
According to Martie Miranda, Head of the Center for Universal Access and Disability Support (CUADS), one of the most important advantages of the SmartDrive machines is that it enhances the independence of students. The devices were bought with funds received from the Department of Higher Education and Training specifically allocated for accessibility and infrastructure.
 
“While the UFS is addressing inaccessibility on its campuses, which will take time, this will help to motorise wheelchairs for wheelchair users to move around more easily. Students can now move around independently without necessarily asking for help, for example, to get up very steep ramps.” Miranda says some surfaces, such as grass and gravel, has its own unique challenges for wheelchair users.

A few years coming

The SmartDrive devices are operated by a Bluetooth watch. By tapping twice on the chair or clapping twice, the motor propels the wheelchair forward and stops when tapped twice, while also braking with one’s hands. The speed can also be controlled by the user. The machines use rechargeable batteries, with a fully charged battery lasting up to 15 hours.
 
Acquiring the devices was a process of a few years, and CUADS is happy to finally employ them to the benefit of their students. Miranda says the determination and support of Prof Nicky Morgan, Vice-Rector: Operations, and the assistance of Nico Janse van Rensburg, Senior Director: Top Management, were instrumental in buying the devices.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept